Kolexia
Zucman David
Médecine interne
Hôpital Foch
Suresnes, France
154 Activités
487 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH Hépatite Hépatite C Co-infection Hépatite C chronique Cirrhose du foie Fibrose Tumeurs du foie Carcinome hépatocellulaire

Industries

MSD
4 collaboration(s)
Dernière en 2023
Gilead
1 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Questioning the "Ease" in disease: Was living with HIV a burden or boost during the first wave of Covid-19 in France? A qualitative study (COVIDHIV).
PloS one   07 mars 2024
Mortality and comorbidities in a Nationwide cohort of HIV-infected adults: comparison to a matched non-HIV adults' cohort, France, 2006-18.
European journal of public health   26 février 2024
Comparison of the Alinity M STI with the GeneXpert CT/NG for the detection of sexually transmitted microorganisms.
Diagnostic microbiology and infectious disease   04 janvier 2024
Acceptability and health-related quality of life among HIV patients switching to a dual therapy with DTG/3TC: Results from PROBI study
HIV medicine Congress 2023   01 décembre 2023
COCOVIH: New data on cascade of care in France up to 2019. Fewer PLWHIV treated than expected
HIV medicine Congress 2023   01 décembre 2023
Perceived benefits of long-acting injectable antiretroviral treatment go beyond pill-burden relief: Aqualitative study (PANTER)
HIV medicine Congress 2023   01 décembre 2023
Assistance and/or autonomy, two principles supporting long-acting injectable antiretroviral treatment administrations in France: A qualitative study (PANTER)
HIV medicine Congress 2023   01 décembre 2023
RHIVIERA-02: A Randomised Phase II Placebo-controlled Trial of Antiretroviral Therapy (ART) Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs) vs ART Plus Placebo During Primary HIV-1 Infection to Study the Impact on Post-treatment HIV Control.
Essai Clinique (Agence nationale de recherches sur le sida et les hépatites virales)   10 novembre 2023
CO13Hepavih: Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With Hepatitis C and Human Immunodeficiency Virus (Collaboration Inter Cohortes et Centres Cliniques de Sujets Co-infectés Par Les Virus de l'immunodéficence Humaine et de l'hépatite C)
Essai Clinique (Merck-Serono)   01 août 2023
Substance use and CD4/CD8 ratio in HIV/HCV co-infected people receiving direct-acting antiviral treatment (ANRS CO13 HEPAVIH).
Journal of viral hepatitis   26 juin 2023